Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-alcoholic Fatty Liver Disease NAFLD”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06707129
What this trial is testing

Establishment of Precise Histological Evaluation Criteria for NASH Fibrosis Reversal

Who this might be right for
Non-alcoholic Fatty Liver Disease
Beijing Municipal Administration of Hospitals 50
Large-scale testing (Phase 3)Study completedNCT01277237
What this trial is testing

The Effect Of Omega-3 Fatty Acids on Non-alcoholic Fatty Liver Disease

Who this might be right for
Non Alcoholic Fatty Liver Disease
University of Edinburgh 50
Post-approval studies (Phase 4)Looking for participantsNCT06374875
What this trial is testing

Fibrosis Lessens After Metabolic Surgery

Who this might be right for
Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)Non-Alcoholic Fatty Liver DiseaseMetabolic Dysfunction-Associated Steatohepatitis (MASH)+2 more
The Cleveland Clinic 120
Not applicableLooking for participantsNCT05385237
What this trial is testing

Identification of Hepatic Fibrosis Using 4D-MRI

Who this might be right for
Liver Diseases
University Hospital, Basel, Switzerland 200
Very early researchActive Not RecruitingNCT06373523
What this trial is testing

MASLD in Primary Hypothyroidism and Efficacy of Dapaglifozin

Who this might be right for
Hepatic Steato-FibrosisNon-Alcoholic Fatty Liver Disease
Post Graduate Institute of Medical Education and Research, Chandigarh 50
Not applicableLooking for participantsNCT06671886
What this trial is testing

NAFLD Clinical Care Pathway

Who this might be right for
NAFLDMASLD
VA Office of Research and Development 32
Large-scale testing (Phase 3)UnknownNCT04193982
What this trial is testing

An Investigator Initiated Prospective, Four Arms Randomized Comparative Study of Efficacy and Safety of Saroglitazar, Vitamin E and Life Style Modification in Patients With Nonalcoholic Fatty Liver Disease (NAFLD)/ Non-alcoholic Steatohepatitis (NASH)

Who this might be right for
NAFLD
Asian Institute of Gastroenterology, India 250
Not applicableUnknownNCT02663388
What this trial is testing

Epigenetic Mechanisms and Severe Obesity (Biological Tissue Collection)

Who this might be right for
ObesityDiabetesMetabolic Diseases+1 more
University of Lorraine 20,000
Very early researchStudy completedNCT02726542
What this trial is testing

Augmenting Growth Hormone to Ameliorate Nonalcoholic Fatty Liver Disease in Adolescents

Who this might be right for
NAFLD
Massachusetts General Hospital 24
Post-approval studies (Phase 4)Study completedNCT04642261
What this trial is testing

Effect of Empagliflozin on Liver Fat in Non-diabetic Patients

Who this might be right for
Non-alcoholic Fatty Liver Disease
The University of Hong Kong 98
Not applicableUnknownNCT01281059
What this trial is testing

Prediction of Severity of Liver Disease Non Alcoholic Fatty Liver Disease in Patients With Suspected NAFLD by a 13C Octanoate Breath Test

Who this might be right for
NAFLD
Hadassah Medical Organization
Not applicableStudy completedNCT04786418
What this trial is testing

Low-Calorie Diet in People With Prediabetes/Metabolic Syndrome

Who this might be right for
ObesityNAFLDFatty Liver+2 more
University of Liverpool 44
Very early researchWithdrawnNCT01807910
What this trial is testing

ER Stress in NAFLD

Who this might be right for
ObesityNAFLD
Vanderbilt University
Testing effectiveness (Phase 2)Study completedNCT03371355
What this trial is testing

Study of ISIS 703802 in Participants With Hypertriglyceridemia, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease

Who this might be right for
NAFLDDiabetes Mellitus, Type 2Hypertriglyceridemia+1 more
Akcea Therapeutics 105
Not applicableUnknownNCT04099147
What this trial is testing

Diagnosis and Characterization of Non-Alcoholic Fatty Liver Disease Based on Artificial Intelligence.

Who this might be right for
Non-alcoholic Fatty Liver Disease (NAFLD)
Instituto de Investigación Marqués de Valdecilla 14,046
Not applicableLooking for participantsNCT03025074
What this trial is testing

Blood Collection Biorepository for Liver Disease Research

Who this might be right for
Non-Alcoholic Steatohepatitis(NASH)Hepatitis CHepatitis B+5 more
State University of New York at Buffalo 1,000
Post-approval studies (Phase 4)Study completedNCT05647915
What this trial is testing

Effects of Berberine in Reducing Abdominal Visceral Adipose Tissue Among Individuals with Obesity and NAFLD

Who this might be right for
ObesityObesity, AbdominalNAFLD
China National Center for Cardiovascular Diseases 337
Not applicableStudy completedNCT05946148
What this trial is testing

Novel Antidiabetic Medications and Their Effect on Liver Steatosis (NAMELS-18)

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseLiver Steatosis
National and Kapodistrian University of Athens 78
Testing effectiveness (Phase 2)Ended earlyNCT04175392
What this trial is testing

Effect of Probiotics in Non-alcoholic Fatty Liver Disease and Steatohepatitis

Who this might be right for
Fatty Liver DiseaseFibrosis, LiverCirrhosis, Liver+1 more
Corewell Health East 14
Testing effectiveness (Phase 2)UnknownNCT00699036
What this trial is testing

Rosiglitazone Versus Rosiglitazone and Metformin Versus Rosiglitazone and Avandia in the Treatment of Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic SteatohepatitisNonalcoholic Fatty Liver Disease
Brooke Army Medical Center 165
Next Page